ArticleStem cell research & therapy2022

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.

Lei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.